United States Department of Agriculture, Agricultural Research Service, Arthropod Borne Animal Diseases Research Unit, Manhattan, KS 66502, USA.
J Virol Methods. 2012 Feb;179(2):373-82. doi: 10.1016/j.jviromet.2011.11.025. Epub 2011 Dec 7.
Rift Valley fever virus (RVFV) is a zoonotic insect transmitted virus endemic to Africa and the Arabian Peninsula. Infection causes abortions and high mortality in newborn ruminants. The overall human infection rate is <1%; however, fatality rates in those with severe clinical disease have been reported as high as 29%. The potential of RVFV as a bioterrorism agent and/or being accidentally introduced into North America is widely recognized. Currently, regional veterinary biosafety level 2 (BSL-2) diagnostic laboratories lack safe, modern, validated diagnostic tests to detect RVFV. An existing one-step real-time RT-PCR (rRT-PCR) assay was modified for quick virus inactivation for use in BSL-2 laboratories, evaluated on serum and tissue samples from experimentally infected lambs and calves, and compared to virus isolation. Viremia was detected in all inoculated sheep with titers reaching 10(6.5) plaque forming units/ml, or up to 10(10) viral RNA copies/ml. Viremia in calves was lower and not detected in all inoculated animals; however, all animals became transiently febrile and were infected as determined by rRT-PCR of tissues. Virus was isolated from rRT-PCR-positive liver and/or spleen in 33% of lamb and 41% of calf samples between 2 and 7 days post inoculation. For RVFV antigen detection, reagents are typically produced at BSL-3Ag or BSL-4 conditions and require inactivation and safety testing for use outside of containment. In this study, antiserum against recombinant RVFV-nucleocapsid (N) was produced to develop an immunohistochemical (IHC) assay which was subsequently evaluated on formalin fixed lamb and calf tissues at BSL-2 laboratory conditions. Antigen was detected by IHC in 79% of rRT-PCR-positive sheep and 70% of rRT-PCR-positive calf tissues tested. Once validated and approved by national regulatory agencies, these assays can be safely produced and distributed to regional diagnostic laboratories, providing capacity for early detection of RVFV in suspected ruminant samples.
裂谷热病毒(RVFV)是一种虫媒传播的人畜共患病病毒,流行于非洲和阿拉伯半岛。感染会导致新生反刍动物流产和高死亡率。总体人类感染率<1%;然而,有严重临床疾病的患者的死亡率据报道高达 29%。RVFV 作为生物恐怖主义制剂和/或意外引入北美的潜力已得到广泛认可。目前,区域兽医生物安全 2 级(BSL-2)诊断实验室缺乏安全、现代、经过验证的诊断检测方法来检测 RVFV。现有的一步实时 RT-PCR(rRT-PCR)检测方法经过修改,可快速灭活病毒,以便在 BSL-2 实验室中使用,该方法在经过实验感染的羔羊和犊牛的血清和组织样本上进行了评估,并与病毒分离进行了比较。所有接种绵羊均检测到病毒血症,滴度达到 10(6.5)噬菌斑形成单位/ml,或高达 10(10)病毒 RNA 拷贝/ml。犊牛的病毒血症较低,所有接种动物均未检测到;然而,所有动物均短暂发热,并通过组织的 rRT-PCR 确定感染。接种后 2 至 7 天,从 rRT-PCR 阳性的肝脏和/或脾脏中分离到病毒的绵羊和犊牛样本分别为 33%和 41%。对于 RVFV 抗原检测,试剂通常在 BSL-3Ag 或 BSL-4 条件下生产,并且需要灭活和安全测试才能在容器外使用。在这项研究中,针对重组 RVFV-核衣壳(N)产生了抗血清,以开发免疫组织化学(IHC)检测方法,随后在 BSL-2 实验室条件下对福尔马林固定的羔羊和犊牛组织进行了评估。在 rRT-PCR 阳性的绵羊和 rRT-PCR 阳性的犊牛组织中,79%和 70%的组织通过 IHC 检测到抗原。一旦通过国家监管机构验证和批准,这些检测方法就可以安全地生产并分发给区域诊断实验室,为疑似反刍动物样本中 RVFV 的早期检测提供能力。